A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Virginia Rhodes, MD
Tempus AI, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pan American Cancer for Oncology
San Juan, Puerto Rico
Active, not recruiting
- City of Hope
Duarte, California, United States
Ravi SalgiaRecruiting - Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
Jacob ThomasRecruiting - University of California, Los Angeles
Los Angeles, California, United States
Deborah WongRecruiting - Stanford
Palo Alto, California, United States
Saad KhanRecruiting - Providence Medical Foundation
Santa Rosa, California, United States
Ian AndersonRecruiting - Morehouse
Atlanta, Georgia, United States
Roland MatthewsRecruiting - Piedmont Healthcare
Atlanta, Georgia, United States
Sope OlugbileRecruiting - Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
Nabil Saba, MDRecruiting - Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Jochen LorchRecruiting - Cancer Care Specialists of Illinois
Decatur, Illinois, United States
James WadeRecruiting - Illinois Cancer Care
Peoria, Illinois, United States
Fahad AsadRecruiting - University of Kansas
Westwood, Kansas, United States
Prakash NeupaneRecruiting - University of Maryland
Baltimore, Maryland, United States
Ranee MehraRecruiting - Dana Farber Cancer Institute
Boston, Massachusetts, United States
Robert HaddadRecruiting - Henry Ford
Detriot, Michigan, United States
Matthew WilkinsRecruiting - Karmanos Cancer Institute
Detroit, Michigan, United States
Ammar Sukari, MDRecruiting - Oncology Hematology Associates
Springfield, Missouri, United States
V. Roger Holden, MD, PHDRecruiting - Washington University in St. Louis
St Louis, Missouri, United States
Douglas Adkins, MDRecruiting - Mount Sinai Hospital
New York, New York, United States
Kryzsztof MisiukiewiczRecruiting - Sanford Fargo
Fargo, North Dakota, United States
Daniel AlmquistRecruiting - University of Cincinnati
Cincinnati, Ohio, United States
Chris Lemmon, MDRecruiting - Cleveland Clinic
Cleveland, Ohio, United States
Shlomo KoyfmanRecruiting - Ohio State University
Columbus, Ohio, United States
Marcelo BonomiRecruiting - University of Pennsylvania
Philadelphia, Pennsylvania, United States
Lova SunRecruiting - Cancer Care Associates of York
York, Pennsylvania, United States
Chanh HuynhRecruiting - Sanford Sioux Falls
Sioux Falls, South Dakota, United States
Steven PowellRecruiting - Vanderbilt University
Nashville, Tennessee, United States
Jennifer ChoeRecruiting - University of Washington
Seattle, Washington, United States
Cristinia RodriguezRecruiting - Thedacare
Appleton, Wisconsin, United States
Matthias WeissRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2024
- Primary completion
- 1 Mar 2028
- Completion
- 1 Mar 2028
- Last update posted
- 12 Jun 2026
- Registered enrollment
- 500
- Registry id
- NCT06163534
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.